Related references
Note: Only part of the references are listed.Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity
Patrick Ostkamp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
The multiple sclerosis prodrome
Naila Makhani et al.
NATURE REVIEWS NEUROLOGY (2021)
Vitamin D, Autoimmune Disease and Rheumatoid Arthritis
Stephanie R. Harrison et al.
CALCIFIED TISSUE INTERNATIONAL (2020)
Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)
William Camu et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Vitamin D enhances responses to interferon-β in MS
Xuan Feng et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Multiple Sclerosis
Daniel S. Reich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
MS Sunshine Study: Sun Exposure But Not Vitamin D Is Associated with Multiple Sclerosis Risk in Blacks and Hispanics
Annette Langer-Gould et al.
NUTRIENTS (2018)
Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis
Laura J. Balcer et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis
Laura J. Balcer et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b
Kathryn C. Fitzgerald et al.
JAMA NEUROLOGY (2015)
The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: Study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis
Pavan Bhargava et al.
CONTEMPORARY CLINICAL TRIALS (2014)
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis
Ellen M. Mowry et al.
ANNALS OF NEUROLOGY (2012)
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis
Merja Soilu-Hanninen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Vitamin D Status Is Associated with Relapse Rate in Pediatric-Onset Multiple Sclerosis
Ellen M. Mowry et al.
ANNALS OF NEUROLOGY (2010)
Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity
Laura J. Balcer et al.
NEUROLOGY (2010)
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
J. M. Burton et al.
NEUROLOGY (2010)
MRI criteria for MS in patients with clinically isolated syndromes
X. Montalban et al.
NEUROLOGY (2010)
Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures
E. M. Mowry et al.
NEUROLOGY (2009)
Gray matter atrophy in multiple sclerosis: A longitudinal study
Elizabeth Fisher et al.
ANNALS OF NEUROLOGY (2008)
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling
Joseph V. Terza et al.
JOURNAL OF HEALTH ECONOMICS (2008)
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis
Kassandra L. Munger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Advances in functional and structural MR image analysis and implementation as FSL
SM Smith et al.
NEUROIMAGE (2004)
Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol
RP Heaney et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2003)
Accurate, robust, and automated longitudinal and cross-sectional brain change analysis
SM Smith et al.
NEUROIMAGE (2002)
Share Paper
